MedPath

Effect of Human Ration on Weight Loss and Bone Health in Overweight Wome

Not Applicable
Conditions
D01.578
G11.427.590.195
C23.888.144.243
Weight loss. Organic mineral homeostase. Bone health.
Registration Number
RBR-4qpj2r
Lead Sponsor
niversidade Federal de Viçosa
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Female gender. IMC higher than 25 and less than 34.9 kg/m2 and age between 24 and 45 years.

Exclusion Criteria

Pregnant or breastfeeding women. Menopausal women or who underwent removal of the uterus. Which used anti-inflammatories. Who presented intolerance or allergy to any ingredient in the product. Which drink´s alcohol or smokes. Who were using the drug for inhibiting appetite. Antidepressants or whatever to interfere in bone mineral metabolism (bisphosphonates, anabolic steroids, calcitonin, fluoride, hormone replacement therapy, androgens, calcium, vitamin D, thiazide diuretics, and statins). Women with a history of conditions or diseases associated with changes in bone mass such as kidney disease (cholelithiasis, chronic renal failure), gastrointestinal disease (celiac disease, chronic liver disease, malabsorption syndrome, gastrectomy or colectomy). History of endocrine disease (hyperparathyroidism, hyperthyroidism or hypothyroidism). Fractures in the last six months. Which had shown restraint for more than two months and showed fluctuations in body weight greater than 5% in the two months before recruitment.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anthropometric and blood pressure evaluation: body weight, height, waist circumference and blood pressure level assessment. Body composition: measurement of body composition (lean and fat). Bone health: measurement of bone mineral content and serum biochemical bone metabolism markers. Iron and zinc bioavailability: biochemical measurements of serum iron, complete blood count, serum ferritin, plasma zinc and erythrocyte.;There were modifications in anthropometric measures weight and waist circumference, but there were no differences between treatments. There was no change in blood pressure level. Body composition and bone health showed no significant changes. The group that consumed Human Ration showed improvement in hemoglobin concentration (P = 0.0001) and were not observed any loss in relation to the absorption of zinc. Erythrocyte zinc and BMI (body mass index) showed a negative correlation r = -0.5123 P = 0.0005.
Secondary Outcome Measures
NameTimeMethod
Food consumption: assessment of dietary intake by 3 day food record and Health eating index. Assessment of physical activity: International Questinário Physical Activity (IPAQ).;Volunteers who consumed Human Ration showed a significant increase in iron intake (P = 0.0002), phosphorus (P < 0.0001), zinc (P < 0.0001) and vitamin E (P = 0.001). There were no changes in physical activity level of the volunteers.
© Copyright 2025. All Rights Reserved by MedPath